LP‐211, a selective 5‐HT7 receptor agonist, increases novelty‐preference and promotes risk‐prone behavior in rats
Rattachement africain : fr, it. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Abstract Gambling disorder is associated to an increased impulsivity, a high level of novelty‐seeking and a dysregulation of the forebrain neurotransmission systems. However, the neurobiological mechanisms of this addictive disorder are not fully understood and no valid pharmacological approach has yet been approved. The present study aimed to investigate the effect of 5‐HT7 receptor (5‐HT7R) stimulation with a brain penetrant and selective agonist, LP‐211 (0.25 and 0.50 mg kg−1 i.p.) during post‐experience consolidation, (i) acutely in a novelty‐preference test (Exp. 1) or (ii) sub‐chronically in the Probabilistic‐Delivery Task (rPDT, commonly used to measure individual differences in risk proneness of rats; Exp. 2). Results of Exp. 1 showed that 5‐HT7R activation improves consolidation of chamber‐shape memory in the novelty‐preference test, leading to significant novelty‐induced hyperactivity and recognition, in conditions where controls displayed a null‐preference. These results suggest that 5‐HT7Rs may be involved in the consolidation of information inherent to spatial environments, facilitating the recognition of novelty. Furthermore, in the operant rPDT (Exp. 2), 5‐HT7R activation shifts the choice towards a larger yet unlikely reward and turns the propensity of rats towards risk‐prone behavior. Thus, 5‐HT7Rs stimulation apparently strengthens the consideration of future, bigger rewards, also enhancing the seeking of it by operant pokes. These effects may well be explained by LP‐211 actions on hippocampal versus prefrontal cortex‐mediated regulations, leading to improved (though suboptimal) strategy formation. However, further experiments are necessary to determine more in depth the serotonergic pathways involved.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.
- Titre Crossref
- LP‐211, a selective 5‐HT<sub>7</sub> receptor agonist, increases novelty‐preference and promotes risk‐prone behavior in rats
- Date Crossref
- 17/08/2017
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.